CIK 0001636651
- Non-accelerated filer
- Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465270895
- Phone
- +1 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-22 | Tardio Jason Chief Operating Officer | Grant or award | +28,125 | 28,125 | ||
| 2024-02-22 | Tardio Jason Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +168,750 | 168,750 | ||
| 2023-02-23 | Tardio Jason Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2022-09-12 | Tardio Jason Chief Operating Officer | Sale | −17,344 | $2.15 | $37K | 0 |
| 2022-04-08 | Tardio Jason Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +87,498 | 87,498 | ||
| 2022-04-08 | Tardio Jason Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-02-03 | Tardio Jason Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2021-07-01 | Tardio Jason Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-02-05 | Tardio Jason Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-12-17 | Tardio Jason Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2020-11-25 | Tardio Jason Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2020-06-19 | Tardio Jason Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-11-18 | Tardio Jason Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 |
Page 1 of 1 · 13 trades